AI Product

Cleerly — Digital Health

AI-powered coronary plaque analysis and quantification from CT angiography, supporting personalized heart attack risk assessment.

Intelligence Summary

Product
  • Active
  • Verified public sources
  • Developer Cleerly
  • Category Digital Health
  • Status Active
  • Latest update 2017: Cleerly founded in Denver by James Min, MD.
  • Documentation Official page
  • Last reviewed Jul 2026
5 Technologies

Official product page

Target customer

Cardiologists, imaging centers, and health systems offering coronary CT angiography for preventive and diagnostic cardiovascular care.

Features & capabilities

Industries: AI in Healthcare; Digital Health

Related reports

Related insights

Overview

AI-powered coronary plaque analysis and quantification from CT angiography, supporting personalized heart attack risk assessment.

Product and company

Cleerly — Digital Health is a verified product offering linked to the Brel Digital company profile for Cleerly.

Use cases

AI-powered coronary plaque analysis and quantification from CT angiography, supporting personalized heart attack risk assessment.

Target customer

Cardiologists, imaging centers, and health systems offering coronary CT angiography for preventive and diagnostic cardiovascular care.

Technologies

Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics.

Sources and references

  • Official product / company source: https://cleerlyhealth.com/press/cpt-1-code-plaque-analyses
  • Supporting source: https://cleerlyhealth.com/press/aetna-approves-coverage-for-cleerly

Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.

Last reviewed

This product profile was last reviewed on 2026-07-14.

Correction request

If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.

Features and capabilities

  • AI-powered coronary plaque analysis and quantification from CT angiography, supporting personalized heart attack risk assessment.

Extracted from the linked company product description already verified on Brel. No capabilities were invented.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Enquire about this product profile

Messages are delivered to contact@breldigital.com.